Atricure Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $569.6M+22.4% YoYTTM through 30 Jun 2026
Net Income $10.6MTTM through 30 Jun 2026
Free Cash Flow $53.1MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 75.0% |
| EBITDA Margin | 5.8% |
| Operating Margin | -1.8% |
| Net Margin | 1.9% |
Returns
-2.3%ROE
-1.8%ROA
2.6%ROIC
Balance Sheet Health
Debt / Equity0.13x
Current Ratio3.96x
Net Debt-$105.6Mnet cash position
Cash & Equivalents$167.8M
Quality Metrics
Altman Z-Score11.74
Piotroski F-Score7 / 9
FCF Margin9.3%
Rule of 4015.8
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $534.5M
Diluted EPS$0.21TTMFY2025: $-0.24
Dividend
No dividend
Capital Allocation
R&D Spend$98M
Capex Intensity2.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| United States | $435.4M | +13.7% | |
| International | $99.2M | +20.2% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.